Stocks · News reference

8-K filing — MiNK Therapeutics, Inc. (INKT)

Aug 13, 2026, 11:40 AMSEC EDGAR

Filed: 2026-08-13 AccNo: 0001193125-26-347907 Size: 215 KB Item 2.02: Results of Operations and Financial Condition

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Aug 13, 2026, 11:40 AM
Checked: Aug 13, 2026, 11:40 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 13, 2026, 1:29 PMBenzinga Insights
MiNK Therapeutics Q2 2026 Earnings Call: Complete Transcript
MiNK Therapeutics (NASDAQ:INKT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
Read original at benzinga
INKT
BenzingaAug 13, 2026, 11:33 AMBenzinga Newsdesk
MiNK Therapeutics Announces Launch Of Paid International Named-Patient Access Program For agenT-797 In Brazil With Orphan Drug Consulting
Read original at benzinga
INKT
BenzingaAug 13, 2026, 11:33 AMBenzinga Newsdesk
MiNK Therapeutics Says First Patients In Randomized Phase 2 C-1300-02 Trial Of agenT-797 Alive At Day 28 With Improved Oxygenation, ARDS Resolution, Vasopressor Liberation
Read original at benzinga
INKT